Our commitment to scientific rigor and transparent validation, from provenance hardening to IRB-approved clinical studies. Here's where we are and where we're going.
Beverly Index is a novel technology built on established neuroscience. We are transparent about what has been validated and what remains to be proven. NOST's three premises are grounded in decades of peer-reviewed research, but the specific application of linguistic analysis as a proxy for neural oscillation measurement is our innovation, and it requires its own validation pathway.
We do not claim peer-reviewed validation for the Beverly Index scoring system at this stage. What we do claim is: rigorous provenance, every parameter in our system is traceable to published clinical research, and a clear, funded roadmap to independent clinical validation.
Every constant, weight, threshold, and classification in the NOUS platform is traceable to published clinical literature. Zero arbitrary parameters.
Systematic internal testing across diverse narrative scenarios, demographic profiles, and clinical presentations to ensure consistency and reliability.
The ultimate standard, independent IRB-approved studies comparing Beverly Index results against established clinical instruments and expert assessments.
In March 2026, we completed a comprehensive system audit, scanning every constant, weight, and threshold across the entire NOUS platform to ensure full traceability to published clinical research.
The system-wide provenance audit examined all scoring parameters across 68 files in the NOUS codebase.
All scoring parameters trace to one or more of these evidence categories.
Beverly Index is actively pursuing grant-funded research partnerships for LOGOS cross-cultural calibration, validating cognitive signature analysis across diverse populations drawing on Italy's Democratic Psychiatry movement and international community mental health frameworks.
We're seeking clinical research partners, academic institutions, and grant-funded collaborators.